At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
TMSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intensive PTSD Treatment Combined With Transcranial Magnetic Stimulation: A Pilot Study
In Brief
A clinical study evaluating TMS for PTSD. Completed, enrolled 6 participants across 1 site.
Detailed Summary
The goal of this study is to determine whether complementing regular intensive PTSD treatment with intermittent theta burst stimulation (iTBS) applied to the right dorsolateral prefrontal cortex (DLPFC) can improve treatment response for individuals attending a 2-week intensive outpatient program (IOP) for PTSD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPTSD
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJan 2022
First PostedFeb 2024
Primary CompletionJun 2025
Study CompletionOct 2025
TodayJul 2026
First PostedFeb 22, 2024
Enrollment StartJan 11, 2022
Primary CompletionJun 27, 2025
Study CompletionOct 27, 2025
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 2.4 years ago
Interventions
TMSdevice
2 sessions of iTBS per day for 5 days